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Sunday, February 8, 2015 121aactivation, increase channel deactivation, and shift the G-V curve to more
positive voltages. A number of reports have also shown that hydrogen can
reduce HERG current by a mechanism that does not involve an effect on
channel deactivation and which likely involves pore block. We have shown
previously that reducing extracellular potassium results in a significant in-
crease in HERG current reduction by a number of extracellular divalent
ions, including calcium, magnesium, cobalt, manganese, and hydrogen.
We show here that current reduction of WT HERG by extracellular calcium
is voltage dependent and that current reduction of the HERG mutant
G628CS631A is significantly reduced compared to WT at all voltages tested.
In addition current reduction of the HERG mutant S631A shows altered
voltage dependence compared to WT HERG. These results suggest that cal-
cium and other divalent ions can block HERG and may interact with the
outer pore of the HERG channel.
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Voltage sensor relaxation may contribute to the slow deactivation kinetics of
hERG channels1. Relaxation stabilizes the voltage sensor in the activated state
resulting in a mode-shift, where the voltage-dependence of channel deactiva-
tion is shifted ~-30 mV compared with that of channel activation. Voltage
clamp fluorimetry (VCF) reports of voltage sensor movement show a similar
shift in the voltage-dependence of S4 return compared with its activation.
However, the mechanism underlying voltage sensor relaxation in hERG is un-
known. In Shaker channels, voltage sensor relaxation has been shown to be
sensitive to the length and composition of the S3-S4 linker2. Here, we as-
sessed the role of S3-S4 linker length and composition in voltage sensor relax-
ation in hERG channels using two constructs: a chimera with the 9 residue
hERG S3-S4 linker substituted with the 31 residue Shaker S3-S4 linker; the
other with the 9 residues of the hERG S3-S4 linker mutated to glycine resi-
dues. In both cases, the robust shifts in the voltage-dependence of ionic cur-
rent deactivation relative to that of activation were preserved (35 and 29
mV in the 31 residue Shaker linker construct (n¼4) and the 9 glycine
construct (n¼5), respectively), suggesting that length and composition of
the S3-S4 linker are not important mediators of hERG channel relaxation.
Instead, we demonstrate that the ionic current mode-shift is reduced by
external protons in a pH-dependent manner with a pKa of 5.5 (n¼5). Further-
more, VCF recordings of voltage sensor movement show that acidic pH
directly inhibits voltage sensor relaxation. These data suggest that external
protons modify voltage sensor relaxation by destabilizing the relaxed confor-
mation and reveal a mechanism by which acidic pH may accelerate hERG
channel deactivation gating kinetics.
1.Tan et al., J.Gen.Physiol. 140:293-306, 2012
2.Priest et al., Biophys.J. 105:2312-2322, 2013
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Drug interactions with cardiac ion channels can cause disturbances to normal
electrical activity in the heart. In particular, hERG channel block has been
linked with QT prolongation and increased pro-arrhythmic risk. Conse-
quently, hERG channel screening, quantifying drug block at different drug
concentrations, forms a routine part of cardiovascular safety assessment.
Recent initiatives led by the US Food and Drug Administration (FDA) aim
to reform the current safety assessment guidelines and in silico approaches
are envisaged to form an integral part of the new regime (Sager et al., Am
Heart J., 2014).
Mathematical ion channel representations, embedded within action potential
models, are typically constructed through fitting to patch clamp data that
are acquired by applying a series of voltage-step protocols. But different
models exhibit disparate behaviour under non-standard protocols; including
physiologically relevant action potential clamps, or clamps mimicking ar-
rhythmogenic behaviour. We demonstrate the influence the choice of hERG
channel representation can have on action potentials simulated from a math-
ematical ventricular myocyte model when predicting drug-induced effects;
indicating the necessity of including accurate descriptions of hERG channel
kinetics.We present novel rapidly fluctuating voltage-clamp protocols, designed
mathematically to enable a robust model of hERG channel kinetics to be
determined, on a cell-specific basis. The protocols have been tested in manual
patch clamp experiments, using hERG-1a transfected HEK 293 cells. The
approach will be extended to determine compound-specific models describing
hERG channel kinetics in the presence of different drugs, which may enhance
the predictive ability of in silico approaches used for cardiovascular safety
assessment.
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Human ether-a-go-go-related gene 1 (hERG1) Kþ channels mediate repo-
larization of action potentials in cardiomyocytes. A refined mechanistic
understanding of the action of hERG1 agonists may assist development
of novel compounds for treatment of arrhythmia associated with acquired
or congenital long QT syndrome. RPR-260243 [(3R,4R)-4-[3-(6-meth
oxy-quinolin-4-yl)-3-oxo-propyl]-1-[3-(2,3,5 trifluorophenyl)-prop-2-ynyl]-
piperidine-3-carboxylic acid] (RPR) profoundly slows deactivation and
modestly attenuates fast C-type inactivation of hERG1 channels without
affecting its kinetics. A Markov model of channel gating incorporating
two open states reproduced these experimental findings. A binding site for
RPR has been localized to a hydrophobic pocket between two adjacent
hERG1 subunits. Accordingly, one homotetrameric hERG1 channel contains
four identical RPR binding sites. In this study, the stoichiometric basis of
RPR-altered hERG1 channel currents was investigated. Concatenated
hERG1 tetramers incorporating a variable number of wild-type subunits
and mutant subunits (L553A to prevent RPR binding) were constructed
and heterologously expressed in Xenopus oocytes. RPR slowed the rate of
hERG1 channel deactivation as a function of the number of wild-type sub-
units (i.e., accessible RPR binding sites) contained within a tetramer. Occu-
pancy of all four available binding sites was required to attain maximum
effect. In contrast, occupancy of only three binding sites was sufficient to
achieve the maximum shift (þ24 mV) in the voltage required for half-
maximal inactivation. The distinct subunit stoichiometries associated with
RPR-induced changes in hERG1 deactivation and inactivation reflects the
different structural basis of the activation (S6 bundle crossing) and inactiva-
tion (selectivity filter) gates.
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Dofetilide is an antiarrhythmic agent used for the maintenance and protection
of sinus rhythm from atrial fibrillations and flutters in individuals. However,
dofetilide is better known for its arrhythogenic activity and blockade of IKr
currents and is limited in clinical use. An inadvertent drug blockade of
hERG channel predisposes to drug-induced Long-QT2 syndrome in humans.
It is well established that dofetilide reversibly binds with moderate-to-high af-
finity to an open state of hERG1 reversibly but irreversibly blocks open-
inactivated state. Here, we used a combination of MD simulations and free
energy simulations to unravel key determinants of state-dependent blockade
of hERG1. It was found that inactivation of the channel and formation of
open-inactivate state of hERG1 leads to narrowly localized high-affinity bind-
ing pocket for dofetilide. The corresponding Potential of Mean Force (PMF)
for drug dissociation from open state of the channel is markedly different. It
shows shallow but broad minima. To place findings from atomistic simula-
tions to cellular context we performed kinetic modeling of IKr currents using
Markov-net models developed previously. The results were compared to elec-
trophysiological recordings of dofetilide binding to WT and 656C mutants of
hERG1 channel.
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We have recently proposed that the linker region between RCK domains in
the cytoplasmic portion of BK channels consists of a Cytochrome-c-like
122a Sunday, February 8, 2015domain, which encompasses a conserved heme regulatory motif (HRM,
612CKACH616 (Tang et al., Nature 2003) and endows BK channels with
catalytic properties (Yusifov et al., Biophys J 2710-Pos 2014). Alignment
of the BK Cytochrome-c-like domain and the human Cytochrome C
(CytC) sequences revealed that they share, in addition to the HRM, key
structural and functional elements. Notably, Met-80 in CytC, which is the
second axial ligand to the heme iron, aligns with BK Met-691. In fact, mu-
tation M691A dramatically reduced the Heme-dependent peroxidase activity
of the purified BK channel Gating Ring. We assessed the involvement M691
in the heme modulation of BK channel conducting properties by inside-out
patch clamp in WT and M691A channels expressed in Xenopus oocytes. The
Kþ current from WT BK channels was reduced by 61.6514.6% (140mV) in
100nM heme. On the contrary, under identical conditions, Kþ current was
reduced by only 13.252.23% in BK channels carrying the M691A muta-
tion. Moreover, the conductance half-activation potential (Vhalf) of WT
BK shifted from 81.253.03 to 12651.67mV after the addition of 100nM
heme. Conversely, in M691A channels, the Vhalf was largely unperturbed
by 100nM heme (from 98.254.13 to 10058.76mV). Thus, M691A essen-
tially eliminated the BK channel sensitivity to heme. These results reinforce
the view that a Cytochrome-c-like domain, which associates heme via
the HRM and a second axial ligand (Met-691) is an integral part of BK
channels.
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Carbon monoxide (CO) is a recognized gasotransmitter that regulates BK chan-
nel activity, causing vasodilatory effects. It is thought that CO interacts with the
intracellular portion of BK channels, which consists of the assembly of struc-
tural domains RCK1 and RCK2 into the ligand-sensing Gating Ring superstruc-
ture. Several mechanisms have been proposed to account for the BK/CO
interaction (Heinemann et al., Chem Commun 2014). We have tested the hy-
pothesis that CO interacts with BK channels via heme, which associates with
the RCK1-RCK2 linker region, previously described as the BK Cytochrome-
c-like domain (Yusifov et al., Biophysical J, 2709-Pos 2014). We investigated
the molecular interaction of CO with the purified human BK channel Gating
Ring using absorption spectroscopy: we found that the spectrum of the Gating
Ring complexed with the reduced form of heme [Fe(II) protoporphyrin-IX] was
significantly altered in the presence of CO and produced a Soret peak at 422 nm
and b/a bands at 538 and 574 nm, typical spectral characteristic of hemopro-
teins complexed with CO. Furthermore, CO-dependent conformational
changes were assessed using ANS (8-Anilino-1-naphthalenesulfonic acid) fluo-
rescence spectra of the Gating Ring/reduced heme complex in the presence of
increasing [CO]. The intensity of GR/ANS emission diminished in a [CO]-
dependent manner (K0.5¼5453.8nM), indicating less ANS association, and
therefore the occurrence of CO-dependent GR structural rearrangements. On
the contrary, when heme was substituted by protoporphyrin-IX, a heme analog
that lacks iron, CO addition did not alter ANS fluorescence. These results sug-
gest that, in BK channels, the Heme/Cytochrome-c-like domain complex acts
as a CO sensor, binding CO via heme and inducing a conformational change
to the BK channel Gating Ring at submicromolar [CO]. This structural transi-
tion likely represents one of the mechanisms underlying the CO-dependent
regulation of the human BK channel.
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High-conductance Ca(2þ)-and voltage-activated K(þ) (Slo1 or BK) channels
play key roles in many normal and pathophysiological processes, such as
sinoatrial node pacing, blood pressure regulation, neurotransmitter release,
autism, and epilepsy. The Slo1 channel can be divided into a trans-
membrane core module comprised of the pore gate domain (PGD) surrounded
by four voltage sensor (VS domains), and a large cytosolic domain (CTD)
which forms an intracellular gating ring. DHA (docosahexaenoic acid), pro-
tons, and DiBAC4(3) (bis-(1,3-dibutylbarbituric acid) trimethine oxonol)
can activate wt BK channels. Our construct of functional Slo1-core channelscomprised of the PGD and VS domains without the CTD provides a tool to
explore drug target domains of BK channels. In this study, we test the action
of DHA, protons, and DiBac4(3) on wt and Slo1-core channels using single-
channel and macro-patch recordings to measure channel activity before and
after application of activating agents. We found that both DHA and Di-
BAC4(3) activate Slo1-core channels. This was the case with or without
beta1 subunits. These results indicate that DHA and DiBAC4(3) do not
require the CTD to activate Slo1 channels. We also found that protons did
not activate Slo1-core channels, which directly shows that protons require
the CTD for their action, while having little or no direct action on the core
of the channel. Our results for DHA and protons are consistent with previous
studies using less direct experimental approaches. Our observation that Di-
BAC4(3) can activate core channels in the absence of the gating ring is a
novel. This study is a clear demonstration of the utility of the functional
Slo1-core constructs we have developed for locating the sites of action of
BK channel enhancers and modulators.
611-Pos Board B391
CadmiumCoordination by Cysteines Introduced in the BK Inner Pore and
its Structural and Functional Implications
Yu Zhou, Xiaoming Xia, Christopher J. Lingle.
Washington University School of Medicine, St. Louis, MO, USA.
By opening and closing a potassium-selective ion permeation pathway in
response to changes of transmembrane potential or intracellular Ca2þ concen-
tration, the BK-type potassium channels serve key roles in many important
physiological processes. To probe conformational changes associated with
gating, we engineered two Cd2þ coordination sites by cysteine substitution
of BK inner pore residues in the S6 inner helix. The first coordination site is
formed by A316C, a pore lining residue located deep inside the BK inner
pore region. Intracellularly applied Cd2þ binds to this site with modest
state-dependence, suggesting that the cytosolic entrance of BK channel does
not significantly occlude metal ion flow even in the closed state. The second
Cd2þ coordination site is formed by V319C, which is in the middle of the
YVP motif (equivalent to Kv PXP motif) near the cytosolic entrance of BK
channel. State-dependence of Cd2þ-V319C coordination is very weak, indi-
cating that the structure of this coordination site remains stable during BK
channel gating. More importantly, our results show that Cd2þ-V319C coordi-
nation involves a native glutamate (E321) from same subunit, which suggests
that the distance between the side chains of V319C and E321 is much shorter
than that observed in Kv channel structures. This result suggests that the
conserved proline in the YVP motif introduces a kink in BK S6 that is sharper
than that observed in Kv channel structures.
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GoSlo-SR-5-6 (GoSlo) is a novel BK channel agonist that shifts the activation
V1/2 of BK channels by >-100 mV when applied at a concentration of 10mM
concentration. Although the structure-activity relationships of the GoSlo-SR
channel agonists has been studied extensively [1], nothing is known about their
mode of action.
GoSlo was as effective on Slo1 a subunits as it was on BK channels from
the rabbit bladder smooth muscle and shifted V1/2 > 100 mV. Similarly,
GoSlo shifted activation V1/2 >-100 mV in truncated BK channels [2]. Its
effects were reduced >50% in the Slo1_9a splice variant [3] and in chi-
meras containing Slo1_9a S6 sequence. Of the three residues that differ
in S6 between Slo1 and Slo1_9a, only the S317R mutant reduced the effects
of GoSlo. We identified two other residues (L227A in S4/S5 linker and
I326A in S6) that, when mutated to alanine, also diminished the effects
of GoSlo significantly. A triple mutation (L227A:S317R:I326A) virtually
abolished the effects of GoSlo (DV1/2 -1554 mV, n¼11). To investigate
the mechanism of action of GoSlo, we used the HA allosteric model [4].
Our data suggests that SR-5-6 interacts with the transmembrane segment
of the channel to enhance pore opening by stabilising the open state
(L0~700 fold), activating the voltage sensors (J0~8 fold), but interestingly
reducing allosteric coupling between the voltage sensors and pore gate
(D) ~60%.
References:
1. Roy et al., (2012). ChemMedChem, 7(10). 1763-1769.
2. Budelli et al., (2013). PNAS 110 (41) 16657-16662.
